FCPAX
Price
$34.86
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Net Assets
15.75B
RERAX
Price
$60.79
Change
-$0.26 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.72B
Interact to see
Advertisement

FCPAX vs RERAX

Header iconFCPAX vs RERAX Comparison
Open Charts FCPAX vs RERAXBanner chart's image
Fidelity Advisor Intl Capl App A
Price$34.86
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets15.75B
American Funds EUPAC R1
Price$60.79
Change-$0.26 (-0.43%)
VolumeN/A
Net Assets137.72B
FCPAX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
FCPAX vs. RERAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCPAX is a StrongBuy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 138B vs. FCPAX (15.8B). FCPAX pays higher dividends than RERAX: FCPAX (0.45) vs RERAX (0.22). FCPAX was incepted earlier than RERAX: FCPAX (28 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FCPAX (1.12). FCPAX is a more actively managed with annual turnover of: 63.00 vs. RERAX (35.00). FCPAX has a lower initial minimum investment than RERAX: FCPAX (0) vs RERAX (250). FCPAX annual gain was more profitable for investors over the last year : 13.04 vs. RERAX (9.84). FCPAX return over 5 years is better than : 37.81 vs. RERAX (9.42).
FCPAXRERAXFCPAX / RERAX
Total Expense Ratio1.121.5771%
Annual Report Gross Expense Ratio1.121.5771%
Fund Existence28 years23 years-
Gain YTD17.69120.54386%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets15.8B138B11%
Annual Yield % from dividends0.450.22205%
Returns for 1 year13.049.84132%
Returns for 3 years76.8345.45169%
Returns for 5 years37.819.42402%
Returns for 10 years132.4535.44374%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO67.030.15
+0.22%
Halozyme Therapeutics
TECTP10.82-0.03
-0.28%
Tectonic Financial
NTWK4.50-0.02
-0.44%
NetSol Technologies
GPCR27.38-0.18
-0.65%
Structure Therapeutics
RXT1.42-0.05
-3.40%
Rackspace Technology